|Panel testing for familial breast cancer: calibrating the tension between research and clinical care|
ER Thompson, SM Rowley, N Li, S McInerny, L Devereux, ...
Journal of Clinical Oncology 34 (13), 1455-1459, 2016
|miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition|
C Sun, N Li, Z Yang, B Zhou, Y He, D Weng, Y Fang, P Wu, P Chen, ...
Journal of the National Cancer Institute 105 (22), 1750-1758, 2013
|Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types|
V van Unen, T Höllt, N Pezzotti, N Li, MJT Reinders, E Eisemann, ...
Nature communications 8 (1), 1-10, 2017
|Mass cytometry of the human mucosal immune system identifies tissue-and disease-associated immune subsets|
V van Unen, N Li, I Molendijk, M Temurhan, T Höllt, ...
Immunity 44 (5), 1227-1239, 2016
|No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing|
DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ...
Journal of medical genetics 53 (5), 298-309, 2016
|The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis|
C Sun, N Li, D Ding, D Weng, L Meng, G Chen, D Ma
PloS one 9 (5), e95285, 2014
|Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis|
C Sun, G Chen, Z Yang, J Jiang, X Yang, N Li, B Zhou, T Zhu, J Wei, ...
Fertility and sterility 100 (3), 782-787. e5, 2013
|Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype|
JE Grolleman, RM de Voer, FA Elsayed, M Nielsen, RDA Weren, C Palles, ...
Cancer cell 35 (2), 256-266. e5, 2019
|Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer|
N Li, C Sun, B Zhou, H Xing, D Ma, G Chen, D Weng
PLoS One 9 (7), e100314, 2014
|miR‑222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1|
C Sun, N Li, B Zhou, Z Yang, D Ding, D Weng, L Meng, S Wang, J Zhou, ...
Oncology letters 6 (2), 507-512, 2013
|Memory CD4+ T cells are generated in the human fetal intestine|
N Li, V van Unen, T Abdelaal, N Guo, SA Kasatskaya, K Ladell, ...
Nature immunology 20 (3), 301-312, 2019
|Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways|
BO Zhou, C Sun, NA Li, W Shan, H Lu, L Guo, E Guo, M Xia, D Weng, ...
International journal of oncology 48 (5), 2087-2097, 2016
|Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine|
N Li, V van Unen, T Höllt, A Thompson, J van Bergen, N Pezzotti, ...
Journal of Experimental Medicine 215 (5), 1383-1396, 2018
|Persistent nociception induces anxiety-like behavior in rodents: role of endogenous neuropeptide S|
S Zhang, X Jin, Z You, S Wang, G Lim, J Yang, M McCabe, N Li, J Marota, ...
PAIN® 155 (8), 1504-1515, 2014
|Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer|
B Zhou, H Xu, M Xia, C Sun, N Li, E Guo, L Guo, W Shan, H Lu, Y Wu, Y Li, ...
Frontiers of medicine 11 (2), 214-222, 2017
|Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls|
ER Thompson, KL Gorringe, SM Rowley, MW Wong-Brown, S McInerny, ...
Breast Cancer Research 17 (1), 1-11, 2015
|Reevaluation of the BRCA2 truncating allele c. 9976A> T (p. Lys3326Ter) in a familial breast cancer context|
ER Thompson, KL Gorringe, SM Rowley, N Li, S McInerny, ...
Scientific reports 5 (1), 1-6, 2015
|Molecular analysis of PALB2‐associated breast cancers|
JEA Lee, N Li, SM Rowley, D Cheasley, M Zethoven, S McInerny, ...
The Journal of pathology 245 (1), 53-60, 2018
|KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer|
H Zhao, E Guo, T Hu, Q Sun, J Wu, X Lin, D Luo, C Sun, C Wang, B Zhou, ...
Oncotarget 7 (28), 43924, 2016
|Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity|
P Lobachevsky, T Leong, P Daly, J Smith, N Best, J Tomaszewski, ...
Cancer letters 383 (2), 212-219, 2016